BACOD regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen ==Overview== {{PAGENAME}} refers to an immunochemoth..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AV}} | {{CMG}}; {{AE}} {{AV}} | ||
{{SK}} | {{SK}} BACOD | ||
BLEO/CTX/DM/DOX/VCR | |||
Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine regimen | |||
==Overview== | ==Overview== | ||
Revision as of 14:36, 27 February 2015
|
WikiDoc Resources for BACOD regimen |
|
Articles |
|---|
|
Most recent articles on BACOD regimen Most cited articles on BACOD regimen |
|
Media |
|
Powerpoint slides on BACOD regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on BACOD regimen at Clinical Trials.gov Trial results on BACOD regimen Clinical Trials on BACOD regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on BACOD regimen NICE Guidance on BACOD regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on BACOD regimen Discussion groups on BACOD regimen Patient Handouts on BACOD regimen Directions to Hospitals Treating BACOD regimen Risk calculators and risk factors for BACOD regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for BACOD regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: BACOD
BLEO/CTX/DM/DOX/VCR
Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine regimen
Overview
BACOD regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.[1][2]
Regimen
H – Doxorubicin (Hydroxydaunomycin)
Indications
References
- ↑ "NCI Thesaurus".
- ↑ "R-CHOP - National Cancer Institute".
- ↑ Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter
|coauthors=ignored (help) - ↑ Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter
|coauthors=ignored (help)